Torthaí cuardaigh - Guangzu Cui

  • 1 - 1 toradh as 1 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    PRMT5 Inhibitor Synergizes with Chemotherapy to Induce Resembling Mismatch Repair Deficiency and Enhance Anti‐TIGIT Therapy in Microsatellite‐Stable Colorectal Cancer

    PRMT5 Inhibitor Synergizes with Chemotherapy to Induce Resembling Mismatch Repair Deficiency and Enhance Anti‐TIGIT Therapy in Microsatellite‐Stable Colorectal Cancer de réir Jiang Zhu, Shenao Fu, Xi Zou, Hanjiang Zeng, Guangzu Cui, Yinghui Peng, Diya Tang, Fan Zhang, Hong Shen, Shan Zeng, Ying Han

    Foilsithe / Cruthaithe 2025-07-01

    Abstract Microsatellite stable (MSS) colorectal cancer (CRC) is considered an “immune‐cold” tumor, accounting for ≈85% of all CRC cases. The overall response rate to chemotherapy combined with immune checkpoint inhibitors in MSS CRC is typically less than 10%. The specific mechanism that enhances ch...

    Cur síos iomlán

    Faigh an téacs iomlán
    Alt

    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: